Wall Street Experts
ver. ZuMIgo(08/25)
Pangaea Oncology, S.A.
Rachunek Zysków i Strat
Przychody TTM (mln): 10
EBIT TTM (mln): -3
index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
Rok finansowy |
2013 |
2014 |
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
Przychód (mln) |
3 |
2 |
2 |
3 |
3 |
3 |
3 |
4 |
5 |
4 |
8 |
Przychód Δ r/r |
0.0% |
-44.4% |
13.5% |
29.2% |
4.1% |
16.7% |
8.4% |
23.6% |
12.3% |
-5.1% |
83.1% |
Marża brutto |
112.7% |
119.6% |
136.8% |
175.1% |
132.5% |
140.3% |
132.9% |
112.5% |
112.4% |
94.1% |
96.9% |
EBIT (mln) |
0 |
-1 |
-1 |
-1 |
-3 |
-2 |
-5 |
-2 |
-1 |
3 |
-3 |
EBIT Δ r/r |
0.0% |
-607.8% |
-8.6% |
-44.3% |
399.2% |
-34.2% |
168.9% |
-65.3% |
-68.0% |
-580.1% |
-207.2% |
EBIT (%) |
6.8% |
-62.1% |
-50.0% |
-21.5% |
-103.3% |
-58.3% |
-144.5% |
-40.6% |
-11.6% |
58.6% |
-34.3% |
Koszty finansowe (mln) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
EBITDA (mln) |
1 |
-0 |
-0 |
1 |
-1 |
1 |
1 |
1 |
0 |
-1 |
-2 |
EBITDA(%) |
24.0% |
-18.0% |
-2.9% |
27.7% |
-25.1% |
18.8% |
23.7% |
16.8% |
7.9% |
-26.9% |
-19.5% |
Podatek (mln) |
0 |
-1 |
-1 |
-1 |
-2 |
-1 |
-0 |
-0 |
-0 |
-0 |
1 |
Zysk Netto (mln) |
0 |
-0 |
-0 |
-1 |
-2 |
-1 |
-5 |
-2 |
-1 |
-3 |
-5 |
Zysk netto Δ r/r |
0.0% |
-353.7% |
147.7% |
22.2% |
177.0% |
-23.9% |
286.4% |
-62.9% |
-64.2% |
322.5% |
71.7% |
Zysk netto (%) |
2.5% |
-11.4% |
-24.9% |
-23.6% |
-62.8% |
-41.0% |
-146.0% |
-43.8% |
-13.9% |
-62.1% |
-58.2% |
EPS |
0.0072 |
-0.0182 |
-0.0452 |
-0.0552 |
-0.15 |
-0.0942 |
-0.28 |
-0.0944 |
-0.0281 |
-0.0891 |
-0.15 |
EPS (rozwodnione) |
0.0072 |
-0.0182 |
-0.0452 |
-0.0552 |
-0.15 |
-0.0942 |
-0.28 |
-0.0944 |
-0.0281 |
-0.0891 |
-0.15 |
Ilośc akcji (mln) |
11 |
11 |
11 |
11 |
11 |
13 |
17 |
19 |
23 |
30 |
30 |
Ważona ilośc akcji (mln) |
11 |
11 |
11 |
11 |
11 |
13 |
17 |
19 |
23 |
30 |
30 |
Waluta |
EUR |
EUR |
EUR |
EUR |
EUR |
EUR |
EUR |
EUR |
EUR |
EUR |
EUR |